35
DAFTAR PUSTAKA
1. Hedrick J. Acute Bacterial Skin Infections in Pediatric Medicine. Pediatr Drugs 2003;1:35-46
2. Craft N, Lee PK, Zipoli MT, Weinberg AN. Pyodermas : Superficial Cutaneus Infections and Pyodermas. Dalam : Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Penyunting. Fitzpatrick’s Dermatology in General Medicine. Edisi ke-7. New York : McGraw Hill 2008:1694-1711
3. Hutahaean NB, K Soenarto. Pola dan Insidens Penyakit Kulit pada Anak di RSUP.Dr. Mohammad Hoesin Palembang. Media Dermato-Venereologica Indonesia 2010;37:154-8
4. Weston WL, Lane AT, Morelli J. Bacterial Infections and spirochetal infections of the skin. Dalam: Weston WL, Lane AT, Morelli J. Color Texbook of Pediatric Dermatology edisi ke-3. Missouri: Mosby Inc, 2002:44-62.
5. Heragandi N. Kuman Penyebab Pioderma Superfisialis pada Anak dan Kepekaannya terhadap beberapa antibiotik (Tesis) Jakarta: Universitas Indonesia 2004.
6. Galen WK, Rogers M, Cohen I, Smith MHD. Bacterial Infections. Dalam : Schachner LA, Hansen RC, penyunting. Pediatric Dermatology. Edisi ke-2, New York Churchill Livingstone 1995:1169-77.
7. Templer SJ, Brito MO. Bacterial Skin and Soft Tissue Infections. Hospital Physician 2009;9-16
8. Stulberg DL, Penrod MA, Blatny RA. Common Bacterial Skin Infections. American Family Physician 2002; 66:119-24.
9. Geria AN, Schuartz RA. Impetigo Update: New Challenges in the Era of Methicillin Resistance. Cutis.2010;85:65-70.
10. Moellering RC. The Problem of Complicated Skin and StructureInfections: the need for new agents. J Antimicrob Chemother 2010;65:3-8
11. Thestrup-Pedersen K. Bacteria and the skin: clinical practice and therapy update. Br J Dermatol 1998;139:1-3
12. Veine NK. The clinican’s choice of antibiotics in the treatment of bacterial skin infection. British J Dermatol 1998;139:30-6
13. Waskito F, Bacterial Infection : General Consideration. Dalam :National Symposium and workshop on Dermatovenereology, Banten, 2010; h.12-4 14. Schweigner ES, Weinberg JM. Novel antibacterial skin and skin structure
infection. J Am Acad Dermatol 2004;50:331-40
15. Brown J, Shriner DL, Schwartz RA, Janniger CK. Impetigo: an update. Int J Dermatol 2003; 42:251-5
16. Hirschmann JV. Impetigo: etiology and therapy. Curr Clin Top Infect Dis.2002;22:42-5
17. Moulin F, Quinet B, Raymond J, Gillet Y, Cohen R. Managing children skin and soft tissue infections. Arch Pediatr. Oct 2008; (15) : 2-6
18. Oumeish I, Oumeish OY, Bataineh O. Acute bacterial skin infections in children. Clinics in Dermatology 2009; 18: 667-78
36
19. Mancini AJ. Bacterial skin infections in children : the common and the not so common. Pediatric Annals 2007; 29 (1): 26-35
20. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Dalam : Emerg nfect Dis. Jun 2005;11(6):928-30.
21. Daskalaki M, Rojo P, Marin-Ferrer M, Barrios M, Otero JR, Chaves F. Panton-Valentine leukocidin - positive Staphylococcus aureus skin and soft tissue Infections among children in an emergency department in Madrid, Spain. Dalam : Clin Microbiol Infect. Jan 2010;16(1):74-7.
22. Elliot DJ, Zaoutis TE, Troxel AB, Loh A, Keren R. Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus.Pediatrics 2009; 123:959-65 23. Bhawani Y, Ramani TV, Sudhakar V. A bacteriological study of 100 cases
of superfisial pustular folliculitis with special reference to staphylococci from lesions and carrir sites. Biology and medicine 2011;3(4):7-12
24. Djuanda A. Pioderma. Dalam: Djuanda A, Hamzah M, Aisyah S, Editor. Ilmu Penyakit Kulit dan Kelamin. Edisi ke-5. Jakarta: Balai Penerbit FKUI 2007:57-63
25. McNeil JC, Huten KG, Kaplan SL, Masen EO. Mupirocin Resitance in Staphylococcus aureus Causing Recurrent Skin and Soft Tissue Infections in Children. Antimicrobial Agents and Chemotherapy 2011; 55: 2431-3 26. George A, Rubin G. A Systematic review and meta-analysis of treatments
for impetigo. Dalam : Br J Gen Pract. Jun 2003;53(491) : 480-7.
27. Upton A, lang S, Heffernan H. Mupirocin and Staphylococus aureus : a recen paradigm of emerging antibiotic resitance. J Antimicroba Chemother 2003;51:613-21
28. Durupt F. Prevalence of Staphylococcus aureus toxins and nasal carriage in furunculosis and impetigo. Dalam : Br J Dermatol 2007: 157-63
29. Kuniyuki S, Nakano K, Maekawa N, Suzuki S. Topical antibiotic treatment of impetigo with tetracycline. J Dermatol. Oct 2005;32(10) :788-92.
30. Treating impetigo in primary care. Drug Ther Bull. Jan 2007;45(1): 2-4 31. Barton LL, Friedman AD. Impetigo: a reassessment of etiology and therapy.
Ped Dermatol 1997; 4(3): 185-8
32. Murray PR, Pfaller MA. Staphylococcus and related organism. Dalam: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA (eds). Medical Microbiology edisi ke-4.MosbyInc,Missouri,2002:202-16.
33. Fridkin SK, Hageman JC, Morrison M.Active Bacterial Core Surveillance Program of the Emerging Infections Program Network Methicillin - resistant Staphylococcus aureus disease in three communities. Engl J Med 2005; 352 :1436-44
34. Indonesian Pediatric Dermatology Study Group. Laporan Morbiditas Sepuluh Penyakit Terbanyak Divisi Dermatologi Pediatrik Se-Indonesia: 2011
